Progress in development of biophysical analytic approaches has recently crossed paths with
macromolecule condensates in cells. These cell condensates, typically termed liquid-like …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an extremely rare tumour, which
usually affects elderly males and presents in the skin with frequent involvement of the bone …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia for
which we developed a nationwide network to collect data from new cases diagnosed in …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an uncommon hematologic
malignancy with poor outcomes. Existing data on the clinical behavior of BPDCN are limited …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy
with historically poor outcomes and no worldwide consensus treatment approach. Unique …

Many studies have shown chemistry proceeds differently in small volumes compared to bulk
phases. However, few studies exist elucidating spontaneous means by which small volumes …

Oncogenesis and ontogeny of blastic plasmacytoid dendritic cell neoplasm (BPDCN) remain
uncertain, between canonical plasmacytoid dendritic cells (pDCs) and AXL+ SIGLEC6+ DCs …

The eukaryotic nucleus is not a homogenous single‐spaced but a highly compartmentalized
organelle, partitioned by various types of membraneless structures, including nucleoli, PML …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy
arising from the aberrant transformation of plasmacytoid dendritic cells (pDCs) and involving …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare clonal hematologic
malignancy of plasmacytoid dendritic cell precursors. The presentation and clinical course of …